Arjun Joshi is a Plastic Surgeon and a Surgical Oncologist in Washington, Washington, D.c.. Dr. Joshi is rated as a Distinguished provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Sialadenitis, Salivary Duct Stones, Laryngeal Cancer, Laryngectomy, and Glossectomy.

Stanley Chia is an Otolaryngologist in Washington, Washington, D.c.. Dr. Chia is rated as a Distinguished provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Adenoid Cystic Carcinoma, Sialadenitis, Acinic Cell Carcinoma of Salivary Glands, Laryngectomy, and Percutaneous Coronary Intervention (PCI).

Bruce Davidson is an Otolaryngologist in Washington, Washington, D.c.. Dr. Davidson is rated as a Distinguished provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Salivary Gland Tumors, Thyroid Cancer, Anaplastic Thyroid Cancer, Thyroidectomy, and Laryngectomy. Dr. Davidson is currently accepting new patients.

Peter Ahn is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Ahn is rated as an Advanced provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Laryngeal Cancer, Adenoid Cystic Carcinoma, Throat Cancer, and Acinic Cell Carcinoma of Salivary Glands.

Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C., and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Listen to Dr. Boudadi’s Cancer Matters podcast episode to learn more about his work. Dr. Boudadi has expertise in treating cancers of the head and neck, including salivary gland cancers, as well as cancers of the esophagus, and bone and soft tissue sarcomas. Having completed dual training in medical oncology and hematology at Johns Hopkins University, Dr. Boudadi also treats patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders, and clotting disorders. Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy. Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine. Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy. Recent News Articles and Media Coverage Cancer Matters Podcast: Dr. Bill Nelson discussing the treatment of HPV related head and neck cancers, Johns Hopkins Kimmel Cancer Center Podcasts (May 23, 2019). Dr. Boudadi is rated as an Experienced provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Glioma, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, Gastrointestinal Stromal Tumor, and Prostatectomy.

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Experienced provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Wojtek Mydlarz, director of Johns Hopkins Head and Neck Surgery in the National Capital Region, specializes in the treatment of benign and malignant tumors of the head and neck, including the upper aerodigestive tract, salivary glands, skull base, thyroid, skin and soft tissue. Dr. Mydlarz is a medical officer and a clinical and research collaborator in the head and neck surgery branch of the National Institutes of Health (NIH). His research interests include evaluating both surgical and nonsurgical treatment outcomes in patients with head and neck cancer. He is interested in the complex molecular biology of head and neck cancer, as well as potential clinical applications of novel targeted cancer therapies. He is actively involved in clinical trial development and implementation at the NIH and Johns Hopkins. After earning his medical degree from the Johns Hopkins University School of Medicine, Dr. Mydlarz completed his internship and residency in otolaryngology–head and neck surgery at The Johns Hopkins Hospital. Additionally, he completed a Science of Clinical Investigation Training Program at Johns Hopkins Bloomberg School of Public Health and specialized fellowship training in head and neck surgical oncology at the University of Texas MD Anderson Cancer Center. Dr. Mydlarz has contributed to numerous professional publications, authored a variety of articles and book chapters, and has been invited to give many lectures. He serves on the editorial board for Oral Oncology and Laryngoscope Investigative Otolaryngology, and is a journal reviewer for Oral Oncology, Head and Neck, Laryngoscope and JAMA Otolaryngology–Head and Neck Surgery. Dr. Mydlarz is rated as an Advanced provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Salivary Gland Tumors, Laryngectomy, and Glossectomy.

Julie Bauman is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Bauman is rated as an Advanced provider by MediFind in the treatment of Salivary Gland Tumors. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Glioma, Tongue Cancer, Nasopharyngeal Carcinoma, and Tissue Biopsy.

Punam Thakkar is an Otolaryngologist in Washington, Washington, D.c.. Dr. Thakkar is rated as an Advanced provider by MediFind in the treatment of Salivary Gland Tumors. Her top areas of expertise are Microtia, Salivary Gland Tumors, Mikulicz Disease, Laryngectomy, and Thyroidectomy.

Matthew Pierce is an Otolaryngologist in Washington, Washington, D.c.. Dr. Pierce is rated as an Advanced provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Oral Squamous Cell Carcinoma, Tongue Cancer, Sialadenitis, Laryngectomy, and Thyroidectomy.

Matthew Witek is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Witek has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Gland Tumors, and Gastrostomy.

Thomas Winkler is an Otolaryngologist and an Oral and Maxillofacial Surgeon in Chevy Chase, Maryland. Dr. Winkler is rated as an Advanced provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are DFNB1, Jones Syndrome, Nonallergic Rhinopathy, and Ozena.

Brandi Page, M.D., is an assistant professor of radiation oncology and molecular sciences for Johns Hopkins Radiation Oncology Department at Suburban Hospital and a radiation oncologist at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Page has expertise in treating all types of cancer and, for the last several years, has become a highly sought-after specialist in the National Capitol Region (NCR-MD/DC/VA) for her expertise in treating head and neck and brain/central nervous system tumors. In Dr. Page's role with Johns Hopkins she has brought new complex radiotherapy services to the facility and facilitated the team building environment for collaborating practitioners and caregivers in the region. Dr. Page also serves on the Cancer Committee for Sibley and Suburban Hospitals for the American Cancer Society, which brings together multidisciplinary care providers to collaborate on initiatives for continued excellence. She is a teaching faculty member at the Johns Hopkins School of Medicine for medical students, residents and fellows, is the current director of radiation oncology fellowships, initiating and growing the first radiation oncology fellowship at the institution a year after the initiation of the proton center. Dr. Page earned her medical degree at Albany Medical College, completed residency in radiation oncology at the Huntsman Cancer Institute at the University of Utah, and fellowship in translational radiation oncology at Wake Forest University Medical Center, where she earned the Service Excellence in Patient Care Award. At Johns Hopkins she has won awards for clinical excellence nominated by peers many years in a row and a Faculty of the Year award for her teaching efforts. Dr. Page is a member of the American Society of Therapeutic Radiation Oncology, a diplomate of the American Board of Radiology, and a Fellow of the American College of Radiation Oncology. Dr. Page has served on the Board of Directors for Radiating Hope and currently serves on the Board of Directors for Courage Unmasked/911-4-HNC (a Head and Neck Cancer support organization). Dr. Page frequently serves as a sought after reviewer for peer reviewed articles and has served as the Continuing Medical Education Editor for the International Journal of Radiation Oncology Biology Physics (IJROBP). Dr. Page believes the best way to empower patients is with knowledge and partnership and she looks forward to partnering with patients in treating their condition, and helping them successfully get through their treatment and maximize opportunities for a happy healthy life after treatment. Make A Gift LinkedIn https://www.linkedin.com/in/brandi-page-968650b0. Dr. Page is rated as an Experienced provider by MediFind in the treatment of Salivary Gland Tumors. Her top areas of expertise are Brain Tumor, Throat Cancer, Laryngeal Cancer, Glioma, and Gamma Knife Radiosurgery.

Nyall London has a unique clinical practice focused on the care of patients with sinonasal and skull base cancers. As one of the few surgeons trained in both head and neck cancer surgery, as well as rhinology and skull base surgery, he offers patients comprehensive sinonasal tumor surgical care, including open and endoscopic approaches as well as neck dissection surgery. Dr. London has developed notable patient education events about the multidisciplinary and long-term care of patients with sinonasal malignancies. Additionally, he is an innovator of clinical trials for these rare tumors, with open clinical trial options available and multiple others in development. Internationally recognized for his expertise in the care of patients with sinonasal and skull base cancers, Dr. London was an associate editor for the first international consensus statement on sinonasal tumors, and was appointed president of the International Network for Sinonasal Cancer Research (2024–26). He directs a research laboratory at the National Cancer Institute/National Institutes of Health focused on therapeutic advances and mechanisms of sinonasal tumorigenesis. Dr. London has published more than 130 peer-reviewed research articles, reviews and book chapters, including co-first author publications in Nature, Nature Medicine, Science Translational Medicine and Nature Cell Biology. He earned his medical and doctoral degrees from the University of Utah, and completed his residency in otolaryngology–head and neck surgery at Johns Hopkins. He also accomplished a fellowship in open and endoscopic head and neck and skull base surgery at The Ohio State University, under the direction of Dr. Ricardo Carrau. Dr. London is rated as an Experienced provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Endoscopy, and Craniectomy.

Mark Goldstein is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Shaun Desai is an Otolaryngologist and a Plastic Surgeon in Bethesda, Maryland. Dr. Desai has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Facial Paralysis, Melanoma, Basal Cell Skin Cancer, Osteotomy, and Bone Graft.

Luther Ampey is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Ampey is rated as an Experienced provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Breast Cancer, Pleuropulmonary Blastoma, Prostate Cancer, and Familial Prostate Cancer. Dr. Ampey is currently accepting new patients.

Catherine Picken is an Otolaryngologist in Washington, Washington, D.c.. Dr. Picken is rated as an Experienced provider by MediFind in the treatment of Salivary Gland Tumors. Her top areas of expertise are Familial Deafness, Infant Hearing Loss, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Otitis, and Balloon Sinuplasty.

Nader Sadeghi is an Otolaryngologist in Washington, Washington, D.c.. Dr. Sadeghi is rated as an Experienced provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Throat Cancer, Hyperparathyroidism, Laryngeal Cancer, Parathyroidectomy, and Gastrostomy.

Yuan Rao is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Salivary Gland Tumors. His top areas of expertise are Vulvar Cancer, Prostate Cancer, Vaginal Cancer, and Familial Prostate Cancer.